Your session is about to expire
← Back to Search
Bronchodilator
COPD group for Chronic Obstructive Pulmonary Disease (CODEx Trial)
N/A
Waitlist Available
Led By François Maltais, M.D
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at the end of the exercise.
Summary
This trial is testing new walking and stepping tests for COPD patients to see if slower stepping speeds can better show improvements in breathing after taking medication.
Eligible Conditions
- Chronic Obstructive Pulmonary Disease
- Shortness of Breath
- Heart Failure
- COPD
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline at 1, 2 and 3 minutes of exercise
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 1, 2 and 3 minutes of exercise
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Symptom perception
Secondary study objectives
Cardiac and ventilatory outcomes
Inspiratory capacity
Maximal inspiratory pressure (PImax)
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: COPD groupExperimental Treatment1 Intervention
Moderate and/or severe COPD patients, corresponding to GOLD stages II and III.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Combination ipratropium/salbutamol or placebo (nebulization)
2009
N/A
~60
Find a Location
Who is running the clinical trial?
Laval UniversityLead Sponsor
430 Previous Clinical Trials
178,355 Total Patients Enrolled
Université de MontréalOTHER
221 Previous Clinical Trials
104,240 Total Patients Enrolled
François Maltais, M.DPrincipal InvestigatorInstitut universitaire de cardiologie et de pneumologie de Québec, University Laval
Share this study with friends
Copy Link
Messenger